Cargando…

MHC Class I-Restricted TCR-Transgenic CD4(+) T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo

In this study we report the functional comparison of T cell receptor (TCR)-engineered major histocompatibility complex (MHC) class I-restricted CD4(+) versus CD8(+) T cells targeting a peptide from six transmembrane epithelial antigen of the prostate 1 (STEAP1) in the context of HLA-A*02:01. STEAP1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schober, Sebastian J., Thiede, Melanie, Gassmann, Hendrik, Prexler, Carolin, Xue, Busheng, Schirmer, David, Wohlleber, Dirk, Stein, Stefanie, Grünewald, Thomas G. P., Busch, Dirk H., Richter, Guenther H. S., Burdach, Stefan E. G., Thiel, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408051/ https://www.ncbi.nlm.nih.gov/pubmed/32610710 http://dx.doi.org/10.3390/cells9071581

Ejemplares similares

Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity
por: Biele, Emilie, et al.
Publicado: (2021)

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer
por: Xue, Busheng, et al.
Publicado: (2022)

Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo
por: Kirschner, Andreas, et al.
Publicado: (2017)

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function
por: Gassmann, Hendrik, et al.
Publicado: (2021)

Human HLA-A*02:01/CHM1(+) allo-restricted T cell receptor transgenic CD8(+) T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo
por: Blaeschke, Franziska, et al.
Publicado: (2016)

Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
por: Schober, Kilian, et al.
Publicado: (2020)

Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8(+) T cells directed against tumor-associated antigens
por: Kirschner, Andreas, et al.
Publicado: (2016)

Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing’s Sarcoma
por: Markey, Fatu Badiane, et al.
Publicado: (2021)

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
por: Evdokimova, Valentina, et al.
Publicado: (2022)

Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
por: Thiel, U, et al.
Publicado: (2011)

Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
por: Thiel, U, et al.
Publicado: (2011)

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma
por: Prexler, Carolin, et al.
Publicado: (2022)

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2021)

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2022)

Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer
por: Liu, Tianshu, et al.
Publicado: (2022)

Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms
por: Gomes, Inês M., et al.
Publicado: (2014)

Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
por: Audehm, Stefan, et al.
Publicado: (2019)

Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma
por: H.S. Richter, Günther, et al.
Publicado: (2020)

TCR–pMHC bond conformation controls TCR ligand discrimination
por: Sasmal, Dibyendu K., et al.
Publicado: (2019)

A T‐cell reporter platform for high‐throughput and reliable investigation of TCR function and biology
por: Müller, Thomas R, et al.
Publicado: (2020)

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide–MHC
por: Hoerter, John A.H., et al.
Publicado: (2013)

The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering
por: Shevyrev, D. V., et al.
Publicado: (2022)

MHC Multimer-Guided and Cell Culture-Independent Isolation of Functional T Cell Receptors from Single Cells Facilitates TCR Identification for Immunotherapy
por: Dössinger, Georg, et al.
Publicado: (2013)

Targeting STEAP1 as an anticancer strategy
por: Nakamura, Hajime, et al.
Publicado: (2023)

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

TCR/pMHC Optimized Protein crystallization Screen
por: Bulek, Anna M., et al.
Publicado: (2012)

Targeting the MHC Ligandome by Use of TCR-Like Antibodies
por: Høydahl, Lene Støkken, et al.
Publicado: (2019)

Targeting cancers through TCR-peptide/MHC interactions
por: He, Qinghua, et al.
Publicado: (2019)

Search for MHC/TCR-Like Systems in Living Organisms
por: Paganini, Julien, et al.
Publicado: (2021)

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
por: Schober, Sebastian Johannes, et al.
Publicado: (2022)

Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
por: Gong, Helong, et al.
Publicado: (2023)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
por: Schendel, Dolores J., et al.
Publicado: (2013)

Force Measurements of TCR/pMHC Recognition at T Cell Surface
por: Puech, Pierre-Henri, et al.
Publicado: (2011)

Genome-wide structural modelling of TCR-pMHC interactions
por: Liu, I-Hsin, et al.
Publicado: (2013)

TCR/pMHC Interaction: Phenotypic Model for an Unsolved Enigma
por: Gálvez, Jesús, et al.
Publicado: (2016)

Integrating Experiment and Theory to Understand TCR-pMHC Dynamics
por: Buckle, Ashley M., et al.
Publicado: (2018)

TCR‐induced alteration of primary MHC peptide anchor residue
por: Madura, Florian, et al.
Publicado: (2019)

Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules
por: Krovi, S. Harsha, et al.
Publicado: (2019)

TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
por: Szeto, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mav3i2dq66vbk8oghsoivn6354